Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies. - Mooney R; Ngai G; Kaur G; Kang EY; Lara J; Abd El-Fattah EE; Huang P; Flores L; McDonald M; Talley M; Hammad M; Laidlaw M; et al. (Molecular therapy. Oncology, 2026)